These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
246 related articles for article (PubMed ID: 20116836)
1. Triage of women with atypical squamous cells of undetermined significance (ASC-US): results of an Italian multicentric study. Del Mistro A; Frayle-Salamanca H; Trevisan R; Matteucci M; Pinarello A; Zambenedetti P; Buoso R; Fantin GP; Zorzi M; Minucci D Gynecol Oncol; 2010 Apr; 117(1):77-81. PubMed ID: 20116836 [TBL] [Abstract][Full Text] [Related]
2. Use of a high-risk human papillomavirus DNA test as the primary test in a cervical cancer screening programme: a population-based cohort study. Zorzi M; Del Mistro A; Farruggio A; de'Bartolomeis L; Frayle-Salamanca H; Baboci L; Bertazzo A; Cocco P; Fedato C; Gennaro M; Marchi N; Penon MG; Cogo C; Ferro A BJOG; 2013 Sep; 120(10):1260-7; discussion 1267-8. PubMed ID: 23786222 [TBL] [Abstract][Full Text] [Related]
3. Human papillomavirus testing as triage for atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesions: sensitivity, specificity, and cost-effectiveness. Kaufman RH; Adam E; Icenogle J; Reeves WC Am J Obstet Gynecol; 1997 Oct; 177(4):930-6. PubMed ID: 9369847 [TBL] [Abstract][Full Text] [Related]
4. Reflex high-risk human papilloma virus DNA test is useful in the triage of women with atypical squamous cells cannot exclude high-grade squamous intraepithelial lesion. Wu HH; Allen SL; Kirkpatrick JL; Elsheikh TM Diagn Cytopathol; 2006 Oct; 34(10):707-10. PubMed ID: 16955480 [TBL] [Abstract][Full Text] [Related]
5. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study. Castle PE; Stoler MH; Wright TC; Sharma A; Wright TL; Behrens CM Lancet Oncol; 2011 Sep; 12(9):880-90. PubMed ID: 21865084 [TBL] [Abstract][Full Text] [Related]
6. HPV testing with cytology triage for cervical cancer screening in routine practice. Louvanto K; Chevarie-Davis M; Ramanakumar AV; Franco EL; Ferenczy A Am J Obstet Gynecol; 2014 May; 210(5):474.e1-7. PubMed ID: 24373948 [TBL] [Abstract][Full Text] [Related]
7. Human papillomavirus (HPV) testing in the management of women with abnormal Pap smears. Experience of a colposcopy referral clinic. Ciotti M; Sesti F; Paba P; Benedetto A; Patrizi L; Criscuolo A; Piccione E; Branca M; Syrjänen K; Favalli C Eur J Gynaecol Oncol; 2004; 25(5):577-84. PubMed ID: 15493169 [TBL] [Abstract][Full Text] [Related]
8. Virologic versus cytologic triage of women with equivocal Pap smears: a meta-analysis of the accuracy to detect high-grade intraepithelial neoplasia. Arbyn M; Buntinx F; Van Ranst M; Paraskevaidis E; Martin-Hirsch P; Dillner J J Natl Cancer Inst; 2004 Feb; 96(4):280-93. PubMed ID: 14970277 [TBL] [Abstract][Full Text] [Related]
9. Comparison of human papillomavirus DNA testing and repeat Papanicolaou test in women with low-grade cervical cytologic abnormalities: a randomized trial. HPV Effectiveness in Lowgrade Paps (HELP) Study No. 1 Group. Lytwyn A; Sellors JW; Mahony JB; Daya D; Chapman W; Ellis N; Roth P; Lorincz AT; Gafni A CMAJ; 2000 Sep; 163(6):701-7. PubMed ID: 11022584 [TBL] [Abstract][Full Text] [Related]
10. Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results. Manos MM; Kinney WK; Hurley LB; Sherman ME; Shieh-Ngai J; Kurman RJ; Ransley JE; Fetterman BJ; Hartinger JS; McIntosh KM; Pawlick GF; Hiatt RA JAMA; 1999 May; 281(17):1605-10. PubMed ID: 10235153 [TBL] [Abstract][Full Text] [Related]
11. Managing atypical squamous cells of undetermined significance in Papanicolaou smears. Morin C; Bairati I; Bouchard C; Fortier M; Roy M; Moore L; Meisels A J Reprod Med; 2001 Sep; 46(9):799-805. PubMed ID: 11584480 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral. Kulasingam SL; Hughes JP; Kiviat NB; Mao C; Weiss NS; Kuypers JM; Koutsky LA JAMA; 2002 Oct; 288(14):1749-57. PubMed ID: 12365959 [TBL] [Abstract][Full Text] [Related]
13. The IMproving Primary Screening And Colposcopy Triage trial: human papillomavirus, cervical cytology, and histopathologic results from the baseline and 1-year follow-up phase. Safaeian M; Wright TC; Stoler MH; Ranger-Moore J; Rehm S; Aslam S; Fang Q; Volkir P; Ridder R Am J Obstet Gynecol; 2021 Sep; 225(3):278.e1-278.e16. PubMed ID: 33852886 [TBL] [Abstract][Full Text] [Related]
14. Silent High Grade Cervical Intraepithelial Neoplasia in Atypical Smears from Liquid Based Cervical Cytology - Three Years Experience in Thammasat University Hospital. Lertvutivivat S; Chanthasenanont A; Chanthasenanont A; Muangto T; Nanthakomon T; Pongrojpaw D; Bhamarapravatana K; Suwannarurk K Asian Pac J Cancer Prev; 2016; 17(9):4353-4356. PubMed ID: 27797243 [TBL] [Abstract][Full Text] [Related]
15. Performance of HPV DNA testing with hybrid capture 2 in triaging women with minor cervical cytologic abnormalities (ASC-US/LSIL) in Northern Thailand. Khunamornpong S; Settakorn J; Sukpan K; Srisomboon J; Suprasert P; Siriaunkgul S Asian Pac J Cancer Prev; 2014; 15(24):10961-6. PubMed ID: 25605209 [TBL] [Abstract][Full Text] [Related]
16. Adjunctive human papillomavirus DNA testing is a useful option in some clinical settings for disease risk assessment and triage of females with ASC-H Papanicolaou test results. Bandyopadhyay S; Austin RM; Dabbs D; Zhao C Arch Pathol Lab Med; 2008 Dec; 132(12):1874-81. PubMed ID: 19061283 [TBL] [Abstract][Full Text] [Related]
17. Cost and effectiveness comparison of immediate colposcopy versus human papillomavirus DNA testing in management of atypical squamous cells of undetermined significance in Turkish women. Kececioglu M; Seckin B; Baser E; Togrul C; Kececioglu TS; Cicek MN; Gungor T Asian Pac J Cancer Prev; 2013; 14(1):511-4. PubMed ID: 23534785 [TBL] [Abstract][Full Text] [Related]
18. Prediction of cervical intraepithelial neoplasia grade 2+ (CIN2+) using HPV DNA testing after a diagnosis of atypical squamous cell of undetermined significance (ASC-US) in Catalonia, Spain. Ibáñez R; Moreno-Crespi J; Sardà M; Autonell J; Fibla M; Gutiérrez C; Lloveras B; Alejo M; Català I; Alameda F; Casas M; Bosch FX; de Sanjosé S BMC Infect Dis; 2012 Jan; 12():25. PubMed ID: 22280073 [TBL] [Abstract][Full Text] [Related]
19. Provider management of equivocal cervical cancer screening results among underserved women, 2009-2011: follow-up of atypical squamous cells of undetermined significance. Watson M; Benard V; Lin L; Rockwell T; Royalty J Cancer Causes Control; 2015 May; 26(5):759-64. PubMed ID: 25794897 [TBL] [Abstract][Full Text] [Related]
20. Team Reading (Peer Review) of Suspicious/Positive Slides for Continuous Quality Improvement in Cervical-Vaginal Cytology: A Comparison between Methods and Indicators. Placidi A; Capparucci P; Di Luzio A; Manca G; Mania E; Filippini T; Giorgi Rossi P Acta Cytol; 2016; 60(5):458-464. PubMed ID: 27504992 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]